I strive to innovate and develop new devices, therapies and treatments to ever improve the cardiac surgery repairs and overall care that we offer to our patients.


Undergraduate Degree

  • Grove City College , 1998 , Grove City , PA

Medical School

  • Temple University School of Medicine , 2004 , Philadelphia , PA


  • Washington University in St. Louis , 2012 , St. Louis , MO


  • Washington University in St. Louis , 2014 , St. Louis , MO


  • Boston Children's Hospital , 2016 , Boston , MA

Philosophy of Care

As a child born with complex congenital heart disease that required two surgeries to repair, I am extremely grateful of the care that I received and the opportunity to live a normal life. It is this personal gratitude that motivates me to provide similar compassionate care to neonates, children and adults with congenital heart disease. The cardiac surgery repair I had required innovation and boldness in an early era of cardiac surgery. With a personal background in engineering, I strive to innovate and develop new devices, therapies and treatments to ever improve the cardiac surgery repairs and overall care that we offer to our patients.


Following my training, I joined the staff at Boston Children's Hospital. My clinical focus is on neonates and children with congenital heart disease. I partner with Dr. Fynn-Thompson in the cardiac assist device and heart and lung transplant programs. Additionally I work as an intensivist in the cardiac intensive care unit. My research is focused on utilizing autologous umbilical veins as a shunt or patch material in neonates with complex congenital heart disease requiring surgery. My lab also focuses on development of devices to improve the safety and effectiveness of cardiac surgery, developing new transplant therapies and lung tissue engineering efforts to improve ECMO and oxygenator technologies.


  • American Board of Thoracic Surgery
  • American Board of Thoracic Surgery, Congenital Heart Surgery


Publications powered by Harvard Catalyst Profiles

  1. Hybrid Left Heart Bypass Circuit for Repair of the Descending Aorta in an 8-kg Williams Syndrome Patient. J Extra Corpor Technol. 2021 Sep; 53(3):186-192. View abstract
  2. Mycobacterium chimaera Outbreak Management and Outcomes at a Large Pediatric Cardiac Surgery Center. Ann Thorac Surg. 2021 Aug 26. View abstract
  3. The Role of Elevated Wall Shear Stress in Progression of Pulmonary Vein Stenosis: Evidence from Two Case Studies. Children (Basel). 2021 Aug 25; 8(9). View abstract
  4. Patch augmentation of small ascending aorta during stage I procedure reduces the risk of morbidity and mortality. Eur J Cardiothorac Surg. 2021 Jul 16. View abstract
  5. A Tribute to Ajit Yoganathan's Cardiovascular Fluid Mechanics Lab: A Survey of Its Contributions to Our Understanding of the Physiology and Management of Single-Ventricle Patients. Cardiovasc Eng Technol. 2021 12; 12(6):631-639. View abstract
  6. A Multi-Mode System for Myocardial Functional and Physiological Assessment during Ex Situ Heart Perfusion. J Extra Corpor Technol. 2020 Dec; 52(4):303-313. View abstract
  7. Technical Performance Score: A Predictor of Outcomes After the Norwood Procedure. Ann Thorac Surg. 2021 10; 112(4):1290-1297. View abstract
  8. Early Infant Symptomatic Patients With Tetralogy of Fallot With Absent Pulmonary Valve: Pulmonary Artery Management and Airway Stabilization. Ann Thorac Surg. 2020 11; 110(5):1644-1650. View abstract
  9. Mitochondrial transplantation for myocardial protection in ex-situ?perfused hearts donated after circulatory death. J Heart Lung Transplant. 2020 11; 39(11):1279-1288. View abstract
  10. Mitochondrial Transplantation for Myocardial Protection in Ex-Situ Perfused Hearts Donated after Cardio-Circulatory Death. J Heart Lung Transplant. 2020 Apr; 39(4S):S87. View abstract
  11. Mechanical Properties of Autologous Pericardium Change With Fixation Time: Implications for Valve Reconstruction. Semin Thorac Cardiovasc Surg. 2019; 31(4):852-854. View abstract
  12. Decellularized extracellular matrix microparticles seeded with bone marrow mesenchymal stromal cells for the treatment of full-thickness cutaneous wounds. J Biomater Appl. 2019 03; 33(8):1070-1079. View abstract
  13. Type B Interrupted Right Aortic Arch: Diagnostic and Surgical Approaches. Ann Thorac Surg. 2019 01; 107(1):e41-e43. View abstract
  14. Pathology of valved venous homografts used as right ventricle-to-pulmonary artery conduits in congenital heart disease surgery. J Thorac Cardiovasc Surg. 2019 01; 157(1):342-350.e3. View abstract
  15. Three-Patch Aortic Root Reconstruction With Extended Left Main Coronary Artery Patch Augmentation in Neonates and Infants. Semin Thorac Cardiovasc Surg. 2019; 31(1):99-101. View abstract
  16. Physiologic effects of delayed sternal closure following stage 1 palliation. Cardiol Young. 2018 Dec; 28(12):1393-1403. View abstract
  17. Impact of a Composite Valved RV-PA Graft After Stage 1 Palliation. Ann Thorac Surg. 2018 11; 106(5):1452-1459. View abstract
  18. Comparison of two pediatric cases requiring the use of bivalirudin during cardiopulmonary bypass. Perfusion. 2018 10; 33(7):525-532. View abstract
  19. Flow Preservation of Umbilical Vein for Autologous Shunt and Cardiovascular Reconstruction. Ann Thorac Surg. 2018 06; 105(6):1809-1818. View abstract
  20. Commentary on Tissue-engineered Solutions For Intracardiac Septal Defects: A Large Step Forward in an Unmet Clinical Need. Ann Surg. 2017 02; 265(2):e13. View abstract
  21. A bilayer small diameter in vitro vascular model for evaluation of drug induced vascular injury. Biomicrofluidics. 2016 Sep; 10(5):054116. View abstract
  22. Rapid isolation of bone marrow mesenchymal stromal cells using integrated centrifuge-based technology. Cytotherapy. 2016 06; 18(6):729-39. View abstract
  23. Decellularized extracellular matrix microparticles as a vehicle for cellular delivery in a model of anastomosis healing. J Biomed Mater Res A. 2016 07; 104(7):1728-35. View abstract
  24. Recommendations for utilization of the paracorporeal lung assist device in neonates and young children with pulmonary hypertension. Pediatr Transplant. 2016 Mar; 20(2):256-70. View abstract
  25. Gas Transfer in Cellularized Collagen-Membrane Gas Exchange Devices. Tissue Eng Part A. 2015 Aug; 21(15-16):2147-55. View abstract
  26. Successful bridge through transplantation with berlin heart ventricular assist device in a child with failing fontan. Ann Thorac Surg. 2015 Feb; 99(2):707-9. View abstract
  27. The surgical prebrief as part of a five-point comprehensive approach to improving pediatric cardiac surgical team communication. World J Pediatr Congenit Heart Surg. 2014 Oct; 5(4):640-2. View abstract
  28. Lung tissue engineering. Front Biosci (Landmark Ed). 2014 Jun 01; 19:1227-39. View abstract
  29. Validation of computational fluid dynamics-based analysis to evaluate hemodynamic significance of access stenosis. J Vasc Access. 2014 Sep-Oct; 15(5):409-14. View abstract
  30. Three-dimensional scaffolds of acellular human and porcine lungs for high throughput studies of lung disease and regeneration. Biomaterials. 2014 Mar; 35(9):2664-79. View abstract
  31. Differentiation of human bone marrow mesenchymal stem cells on decellularized extracellular matrix materials. J Biomed Mater Res A. 2014 Aug; 102(8):2875-83. View abstract
  32. Paracorporeal lung assist devices as a bridge to recovery or lung transplantation in neonates and young children. J Thorac Cardiovasc Surg. 2014 Jan; 147(1):420-6. View abstract
  33. Neonatal paracorporeal lung assist device for respiratory failure. Ann Thorac Surg. 2013 Feb; 95(2):692-4. View abstract
  34. Influence of vascular network design on gas transfer in lung assist device technology. ASAIO J. 2011 Nov-Dec; 57(6):533-8. View abstract
  35. Ultra-thin, gas permeable free-standing and composite membranes for microfluidic lung assist devices. Biomaterials. 2011 Jun; 32(16):3883-9. View abstract
  36. Lung assist device technology with physiologic blood flow developed on a tissue engineered scaffold platform. Lab Chip. 2011 Feb 21; 11(4):700-7. View abstract
  37. Branched vascular network architecture: a new approach to lung assist device technology. J Thorac Cardiovasc Surg. 2010 Nov; 140(5):990-5. View abstract
  38. Preserved extracellular matrix components and retained biological activity in decellularized porcine mesothelium. Biomaterials. 2010 Sep; 31(27):6934-40. View abstract
  39. The retention of extracellular matrix proteins and angiogenic and mitogenic cytokines in a decellularized porcine dermis. Biomaterials. 2010 Sep; 31(26):6730-7. View abstract
  40. Principles of biomimetic vascular network design applied to a tissue-engineered liver scaffold. Tissue Eng Part A. 2010 May; 16(5):1469-77. View abstract
  41. Poly(glycerol sebacate) films prevent postoperative adhesions and allow laparoscopic placement. Surgery. 2009 Sep; 146(3):490-7. View abstract
  42. Tissue engineering and organ structure: a vascularized approach to liver and lung. Pediatr Res. 2008 May; 63(5):520-6. View abstract
  43. Use of an apical heart suction device for exposure in lung transplantation. Ann Thorac Surg. 2006 Apr; 81(4):1524-5. View abstract